This page shows the publications co-authored by Stacey Gray and George Scangas.
Private payer-negotiated prices for FDA-approved biologic treatments for allergic diseases. Int Forum Allergy Rhinol. 2021 Nov 24.
Off-label Treatment in Otolaryngology-A Cautionary Tale. JAMA Otolaryngol Head Neck Surg. 2019 May 01; 145(5):399-400.
Does bilateral inferior turbinate reduction affect long-term quality-of-life outcomes in patients undergoing endoscopic sinus surgery? Int Forum Allergy Rhinol. 2019 06; 9(6):601-606.
Does the Timing of Middle Turbinate Resection Influence Quality-of-Life Outcomes for Patients with Chronic Rhinosinusitis? Otolaryngol Head Neck Surg. 2017 11; 157(5):874-879.
Skull base erosion and associated complications in sphenoid sinus fungal balls. Allergy Rhinol (Providence). 2016 Jan 01; 7(4):227-232.
Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID-19: Risks and Recommendations. Otolaryngol Head Neck Surg. 2020 09; 163(3):465-470.
Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020 Jul; 10(7):798-805.
EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Laryngoscope. 2015 May; 125(5):1056-61.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.